British Columbia, Canada-based Lexaria Bioscience (CSE: LXX)
(OTCQX: LXRP) is a biotechnology company and developer of technology which has
demonstrated faster and more effective delivery of cannabinoids and nicotine.
Recently, LXRP raised funds through a non-brokered private placement that it
intends to use toward the construction of a new Canadian lab, research &
development and general corporate purposes. A recent article discussing the
company reads, “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has raised,
in a non-brokered private placement, a total of $1,515,440. Net proceeds will
be used for construction of a new lab in Canada, LXRP-driven R&D and
general corporate purposes. The offering consists of 947,150 units at an issue
price of $1.60 per unit (http://ibn.fm/WioGm).
Lexaria, due to strong demand, increased the size of the placement.”
To view the full article, visit http://ibn.fm/F6KeL
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com.
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries, including
energy, entertainment, telecommunications, healthcare, retail and more, these
news breaks deliver opportunities the investment community may have missed.
Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment